HGF has one of the largest and most experienced pharmaceutical patent attorney/lawyer teams in Europe. Many of our attorneys and solicitors have joined from large pharmaceutical companies and bring extensive in-house experience of building, managing enforcing and defending global patent portfolios protecting some of the highest profile medicines in Europe.
Our multidisciplinary team supports clients through all stages of the development and lifespan of a pharmaceutical product. We specialise in providing IP strategy advice, invention capture, drafting and filing patent applications, patent prosecution, infringement analysis, EPO oppositions/appeals, commercialisation across the life cycle and multi-jurisdictional patent litigation. We also have specialist experience of supplementary protection certificates (SPCs), regulatory data exclusivity and IP due diligence. A large part of our pharmaceutical practice involves contentious proceedings in the courts and at the EPO. A number of our experienced patent attorneys specialise in opposition and appeal proceedings before the European Patent Office and are regularly involved with complex and high-value multi-party oppositions. Our team of solicitors, working together with our patent attorneys, are also regularly involved in high-profile pharmaceutical patent disputes i nthe national Courts and across Europe.
In terms of technical expertise, our multidisciplinary team specialises in IP relating to drug compounds, particular forms of drug compounds (salt, solvates and polymorphs), formulations (including advanced drug delivery systems), processes for making drug compounds, methods of treatment and therapeutic uses (including drug repositioning), dosage regimens, combination therapies, drug conjugates (such as antibody drug conjugates and PROTACs) and neutraceuticals.
We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.
HGF’s team has pharmaceuticals professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.
From 1 October 2022 Montenegro will become a member state of the EPO. European patent applications (including European Regional Phase applications derived from an International PCT application) which are filed …Read article
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
We are delighted to launch our new Fashionably IP Podcast were we will be looking at important hot topics in the world of fashion and intellectual property. In the podcast, …Read article
HGF is a gold sponsor at the BioCap Conference 2022. The conference will be held on Thursday 22 September at the Alderley Park Conference Centre. It connects life sciences businesses, …Event details
On Friday 9th September 2022, the Grand Board of Appeal of the European Union Intellectual Property Office (‘EUIPO’) held its first ever oral hearing. The Hearing which was live streamed …Read article
As a firm we have been deeply saddened by the news of Queen Elizabeth II death. The Queen has been a constant in our lives throughout some turbulent decades, remaining …Read article